Can You Use Ultrasound Therapy Over Metal Implants? Yes, With Caveats

Yes, you can use ultrasound therapy over metal implants, but only with adjusted technique. Bone conducts ultrasound far better than soft tissue, and metal reflects it almost completely. That mismatch means the energy behaves differently at an implant interface than it does in muscle or tendon. Modern orthopedic implants are mostly titanium alloy or cobalt-chromium, and both are acoustically opaque. The therapy still works, but the dose that reaches tissue near the metal is not the dose you set on the dial. Clinicians who understand this can treat safely. Those who do not can cause a focal burn.

How Ultrasound Energy Meets Metal

Therapeutic ultrasound typically runs at 1 or 3 MHz. At 1 MHz, about 50 percent of the energy is absorbed within the first 5 cm of soft tissue. At 3 MHz, absorption is roughly ten times higher per centimeter, so useful penetration drops to about 1 to 2 cm. These figures come from classic absorption studies summarized in physical therapy texts and professional society guidance.

Metal changes that picture. The acoustic impedance of titanium alloy is roughly 27 to 28 MRayl, and cobalt-chromium is higher still. Soft tissue sits near 1.5 MRayl. At that boundary, most of the incident wave reflects back rather than crossing into the metal. Reflection is not the whole story. Some energy converts to heat at the interface. The rest scatters and creates standing waves in the thin fluid layer between tissue and implant.

The clinical consequence is a hot spot. The tissue immediately overlying the implant can absorb more energy than the same tissue would without metal beneath it. This is why the American Institute of Ultrasound in Medicine and physical therapy safety literature treat metal as a relative, not absolute, contraindication. The risk is thermal, not mechanical, in most cases.

Energy, Dose, and What the Numbers Mean

Ultrasound dose is described by intensity in watts per square centimeter and by spatial-average temporal-average intensity, usually written SATA. Typical therapeutic ranges run 0.5 to 2.0 W/cm² continuous, or up to 3.0 W/cm² pulsed at 20 to 50 percent duty cycle. Pulsed modes deliver lower average heating while preserving mechanical effects.

Near metal, effective intensity can rise. Bench studies of heating over titanium plates report temperature increases several times higher than over soft tissue alone at the same setting. A 1.5 W/cm² continuous application that feels warm over muscle may produce a sharp, localized heat over a plate. That is the number that matters clinically.

The takeaway is dose reduction, not avoidance. Most published protocols for tissue overlying implants recommend starting at 0.5 to 1.0 W/cm² continuous or using pulsed mode at 1.0 to 1.5 W/cm². The aim is to keep tissue temperature below the 41 to 45 °C range where thermal damage begins.

Time Course of Heating and Tissue Response

The table reflects general thermal physiology, not a specific device protocol. The narrow window between useful warming and harmful heating is why treatment time over implants is often capped at 5 minutes or less.

Edge Cases That Change the Decision

Not all implants behave the same. Superficial plates under thin skin, such as distal radius or tibial hardware, sit close to the transducer and get more energy. Deep implants like a hip stem are shielded by centimeters of muscle, which absorbs much of the beam before it reaches metal.

Implant type matters too. Titanium and cobalt-chromium reflect strongly. Polymer spacers and bone cement absorb differently. Cement, in particular, can heat and is a known concern in some literature because polymerization and thermal properties differ from bone.

There is a counterintuitive point here. An implant with no overlying soft tissue complaint may be the riskiest to treat, because the clinician cannot feel the tissue response through the device. The skin tells you less when a rigid plate sits beneath it.

Misconceptions Worth Correcting

One common belief is that metal blocks all ultrasound, so treatment is pointless. Reflection is strong, but not total, and scattering still delivers some energy to surrounding tissue. The therapy is not void.

Another misconception is that metal acts as a heat sink that protects tissue. The opposite is often true near the surface. Metal reflects energy back into the overlying tissue, concentrating heat rather than draining it.

A third is that pulsed mode is always safe over implants. Pulsing lowers average intensity but does not eliminate interface heating, especially at higher peak intensities.

Practical Actions Before You Treat

Confirm the implant location and depth from imaging or the surgical report. Start at 0.5 to 1.0 W/cm² continuous, or use pulsed mode at 1.0 to 1.5 W/cm². Cap continuous treatment over superficial hardware at about 5 minutes. Keep the transducer moving at roughly 2 to 4 cm per second to avoid standing hot spots. Ask the patient to report sharp heat, aching, or numbness immediately. Stop and reassess if symptoms appear over the implant.

These steps reconcile the different thresholds in the literature. Some sources recommend avoiding continuous ultrasound entirely over metal. Others allow it at reduced dose. The practical middle ground is low intensity, short duration, and constant motion.

Red-Flag Warnings

Sharp, localized pain over hardware during treatment. A hot spot the patient describes as burning rather than warming. Numbness or tingling that was not present before the session. Skin that looks flushed or mottled directly over the implant. Any treatment over hardware within weeks of surgery, when healing tissue is fragile.

How Ultrasound Compares With Alternatives

The comparison shows ultrasound is not the only option. When hardware is superficial and the target is shallow, non-thermal modalities may be the safer first choice.

Limits of the Evidence and What to Watch

Much of the implant-specific guidance is extrapolated from bench heating studies and general thermal safety principles, not large clinical trials. That means the exact safe intensity over a given implant is not firmly established. Clinicians should treat published cutoffs as conservative starting points, not guarantees.

Device calibration also matters. A transducer that outputs 20 percent more than its display suggests can push a borderline safe treatment into a risky one. Annual calibration is standard practice, but not universal.

Finally, the question of whether ultrasound helps tissue over an implant is separate from whether it is safe. Evidence for accelerated healing near hardware is limited. The therapy is best framed as a comfort and mobility adjunct, with the implant as a dose-modifying factor rather than a reason to abandon treatment altogether.